{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T14:48:55Z","timestamp":1773413335898,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-026-04715-w","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T14:39:10Z","timestamp":1770647950000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anti-gad autoimmune encephalitis: a case report"],"prefix":"10.1186","volume":"26","author":[{"given":"Kiana","family":"Ketabi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahboubeh","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fariborz","family":"Rezayitalab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Baghestani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pardis","family":"Oliazadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fereshte","family":"Sheybani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"4715_CR1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00415-009-5431-9","volume":"257","author":"F Graus","year":"2010","unstructured":"Graus F, Saiz A, Dalmau J. Antibodies and neuronal autoimmune disorders of the CNS. J Neurol. 2010;257:509\u201317.","journal-title":"J Neurol"},{"issue":"10","key":"4715_CR2","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.3390\/ijms21103701","volume":"21","author":"M Dade","year":"2020","unstructured":"Dade M, Berzero G, Izquierdo C, et al. Neurological syndromes associated with anti-GAD antibodies. Int J Mol Sci. 2020;21(10):3701.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4715_CR3","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1136\/jnnp-2020-325275","volume":"92","author":"A Budhram","year":"2021","unstructured":"Budhram A, Sechi E, Flanagan EP, et al. Clinical spectrum of high-titre GAD65 antibodies. J Neurol Neurosurg Psychiatry. 2021;92(6):645\u201354.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4715_CR4","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00401-011-0876-1","volume":"122","author":"A McKeon","year":"2011","unstructured":"McKeon A, Pittock SJ. Paraneoplastic encephalomyelopathies: pathology and mechanisms. Acta Neuropathol. 2011;122:381\u2013400.","journal-title":"Acta Neuropathol"},{"issue":"9","key":"4715_CR5","doi-asserted-by":"publisher","first-page":"4863","DOI":"10.4049\/jimmunol.0903728","volume":"184","author":"AR Burton","year":"2010","unstructured":"Burton AR, Baquet Z, Eisenbarth GS, et al. Central nervous system destruction mediated by glutamic acid decarboxylase-specific CD4\u2009+\u2009T cells. J Immunol. 2010;184(9):4863\u201370.","journal-title":"J Immunol"},{"issue":"10","key":"4715_CR6","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1093\/brain\/awn183","volume":"131","author":"A Saiz","year":"2008","unstructured":"Saiz A, Blanco Y, Sabater L, et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain. 2008;131(10):2553\u201363.","journal-title":"Brain"},{"issue":"3","key":"4715_CR7","doi-asserted-by":"publisher","first-page":"e0121364","DOI":"10.1371\/journal.pone.0121364","volume":"10","author":"N Gresa-Arribas","year":"2015","unstructured":"Gresa-Arribas N, Ari\u00f1o H, Mart\u00ednez-Hern\u00e1ndez E, et al. Antibodies to inhibitory synaptic proteins in neurological syndromes associated with glutamic acid decarboxylase autoimmunity. PLoS ONE. 2015;10(3):e0121364.","journal-title":"PLoS ONE"},{"issue":"4","key":"4715_CR8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(4):391\u2013404.","journal-title":"Lancet Neurol"},{"issue":"5","key":"4715_CR9","doi-asserted-by":"publisher","first-page":"785","DOI":"10.4103\/aian.aian_644_23","volume":"26","author":"M Vegda","year":"2023","unstructured":"Vegda M, Mehndiratta M. GAD-65-Associated limbic Encephalitis - Early diagnosis and course of Disease, treated with IV Methylprednisolone. Ann Indian Acad Neurol. 2023;26(5):785\u20137.","journal-title":"Ann Indian Acad Neurol"},{"key":"4715_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00234-018-1976-6","volume":"60","author":"JR Fredriksen","year":"2018","unstructured":"Fredriksen JR, Carr CM, Koeller KK, et al. MRI findings in glutamic acid decarboxylase associated autoimmune epilepsy. Neuroradiology. 2018;60:239\u201345.","journal-title":"Neuroradiology"},{"issue":"3","key":"4715_CR11","doi-asserted-by":"publisher","first-page":"312","DOI":"10.31486\/toj.20.0096","volume":"21","author":"S Azizi","year":"2021","unstructured":"Azizi S, Vadlamuri DL, Cannizzaro LA. Treatment of Anti-GAD65 autoimmune encephalitis with Methylprednisolone. Ochsner J. 2021;21(3):312\u20135.","journal-title":"Ochsner J"},{"issue":"6","key":"4715_CR12","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1007\/s10072-024-07933-7","volume":"46","author":"Z Kuang","year":"2025","unstructured":"Kuang Z, Baizabal-Carvallo JF, Alonso-Juarez M, et al. The limbic and extra-limbic encephalitis associated with glutamic acid decarboxylase (GAD)-65 antibodies: an observational study. Neurol Sciences: Official J Italian Neurol Soc Italian Soc Clin Neurophysiol. 2025;46(6):2765\u201377.","journal-title":"Neurol Sciences: Official J Italian Neurol Soc Italian Soc Clin Neurophysiol"},{"key":"4715_CR13","doi-asserted-by":"publisher","first-page":"1081580","DOI":"10.3389\/fnins.2022.1081580","volume":"16","author":"JY Hou","year":"2022","unstructured":"Hou JY, Liu HU, Kuo CY, et al. The clinical relevance of anti-glutamic acid decarboxylase antibodies in children with encephalitis\/encephalopathy. Front NeuroSci. 2022;16:1081580.","journal-title":"Front NeuroSci"},{"key":"4715_CR14","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1007\/s10072-021-05506-6","volume":"42","author":"AS Emekli","year":"2021","unstructured":"Emekli AS, Parlak A, G\u00f6cen NY, et al. Anti-GAD associated post-infectious cerebellitis after COVID-19 infection. Neurol Sci. 2021;42:3995\u20134002.","journal-title":"Neurol Sci"},{"key":"4715_CR15","doi-asserted-by":"publisher","first-page":"813487","DOI":"10.3389\/fimmu.2021.813487","volume":"12","author":"Y Zlotnik","year":"2022","unstructured":"Zlotnik Y, Gadoth A, Abu-Salameh I, et al. Case report: anti-LGI1 encephalitis following COVID-19 vaccination. Front Immunol. 2022;12:813487.","journal-title":"Front Immunol"},{"issue":"3","key":"4715_CR16","first-page":"283","volume":"60","author":"\u00c7 Deniz","year":"2023","unstructured":"Deniz \u00c7, Altunan B, \u00dcnal A. Anti-GAD encephalitis following COVID-19 vaccination: A case report. Archives Neuropsychiatry. 2023;60(3):283.","journal-title":"Archives Neuropsychiatry"},{"issue":"9","key":"4715_CR17","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1708712","volume":"378","author":"J Dalmau","year":"2018","unstructured":"Dalmau J, Graus F. Antibody-mediated encephalitis. N Engl J Med. 2018;378(9):840\u201351.","journal-title":"N Engl J Med"},{"key":"4715_CR18","unstructured":"Thaler FS, Zimmermann L, Kammermeier S et al. Rituximab treatment and Long-term outcome of patients with autoimmune encephalitis: Real-world evidence from the GENERATE registry. Neurology(R) Neuroimmunol Neuroinflammation. 2021;8(6)."}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-04715-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04715-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04715-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T10:30:05Z","timestamp":1773397805000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-04715-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4715"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-04715-w","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"15 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent was obtained from the patient included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent has been obtained from the involved patient or if appropriate from the parent, guardian, power of attorney of the involved patient.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"167"}}